<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Alder Bio and its yeast-produced antibodies take in $40M</title>
	<atom:link href="http://venturebeat.com/2008/01/11/alder-bio-and-its-yeast-produced-antibodies-take-in-40m/feed/" rel="self" type="application/rss+xml" />
	<link>http://venturebeat.com/2008/01/11/alder-bio-and-its-yeast-produced-antibodies-take-in-40m/</link>
	<description>News About Tech, Money and Innovation</description>
	<lastBuildDate>Wed, 25 Nov 2009 06:07:42 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Life-science briefing: Tuesday, March 25, 2008 &#187; VentureBeat</title>
		<link>http://venturebeat.com/2008/01/11/alder-bio-and-its-yeast-produced-antibodies-take-in-40m/comment-page-1/#comment-800183</link>
		<dc:creator>Life-science briefing: Tuesday, March 25, 2008 &#187; VentureBeat</dc:creator>
		<pubDate>Tue, 25 Mar 2008 14:22:03 +0000</pubDate>
		<guid isPermaLink="false">http://venturebeat.com/2008/01/11/alder-biotherapeutics-and-its-yeast-produced-antibodies-take-in-40m/#comment-800183</guid>
		<description>[...] drugs in bioengineered yeast cells, as we wrote at the time. (Alder Biopharmaceuticals, which raised $40 million in January, is another.) The technique promises to be much faster &#8212; and freer of patent restrictions [...]</description>
		<content:encoded><![CDATA[<p>[...] drugs in bioengineered yeast cells, as we wrote at the time. (Alder Biopharmaceuticals, which raised $40 million in January, is another.) The technique promises to be much faster &#8212; and freer of patent restrictions [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
